NICE recommends use of smoking cessation therapies

The National Institute for Clinical Excellence have recommended the use of bupropion (Zyban) and nicotine replacement therapy (NRT) for smokers who wish to quit.

The guidance states that NRT or bupropion should normally only be prescribed when smokers have made a commitment to stop smoking on or before a certain date (‘target stop date), in conjunction with advice and encouragement to help them quit.

First prescriptions of NRT or bupropion should only be enough to last until 2 weeks after the target stop date. Normally, this will be 2 weeks for NRT. For bupropion it will be 34 weeks, because bupropion should be taken for about 1 week before the target stop date. Smokers should only be given a second prescription for NRT or bupropion if they can show they are still trying to stop smoking.

In deciding which of the available therapies to use and in which order they should be prescribed, doctors should take the following factors into account:

The smokers intention and motivation to quit, and how likely it is they will follow the course of treatment as prescribed.

Whether counselling and support are available.

Whether the smoker has used treatments to attempt to stop smoking in the past.

Whether there are medical reasons why the smoker should not be prescribed NRT or bupropion, and whether they are likely to experience adverse effects with either treatment.

Which treatment the smoker would prefer to use.

ניתן להוריד את ההנחיות המלאות כקבצי PDF מהאתר.

להנחיות המלאות

0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים

הנך גולש/ת באתר כאורח/ת.

במידה והנך מנוי את/ה מוזמן/ת לבצע כניסה מזוהה וליהנות מגישה לכל התכנים המיועדים למנויים
להמשך גלישה כאורח סגור חלון זה